Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with 18F-DPA-714 and micro-PET/CT

@article{Gargiulo2016ImagingOB,
  title={Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with 18F-DPA-714 and micro-PET/CT},
  author={Sara Gargiulo and Serenella Anzilotti and Anna Rita Daniela Coda and Matteo Gramanzini and Adelaide Greco and Maria Rosaria Panico and Agatino Vinciguerra and Antonella Zannetti and Caterina Vicidomini and Fr{\'e}d{\'e}ric Doll{\'e} and Giuseppe Pignataro and Mario Quarantelli and Lucio Annunziato and Arturo Brunetti and Marco Salvatore and Sabina Pappat{\`a}},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2016},
  volume={43},
  pages={1348-1359}
}
PurposeTo evaluate the feasibility and sensitivity of 18F-DPA-714 for the study of microglial activation in the brain and spinal cord of transgenic SOD1G93A mice using high-resolution PET/CT and to evaluate the Iba1 and TSPO expression with immunohistochemistry.MethodsNine symptomatic SOD1G93A mice (aged 117 ± 12.7 days, clinical score range 1 – 4) and five WT SOD1 control mice (aged 108 ± 28.5 days) underwent 18F-DPA-714 PET/CT. SUV ratios were calculated by normalizing the cerebellar (rCRB… 

In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis

Preliminary results suggest that both activated microglia and infiltrated macrophages are present in vulnerable brain regions during the acute phase of PLP-EAE and contribute to disease severity.

Cellular Sources and Regional Variations in the Expression of the Neuroinflammatory Marker Translocator Protein (TSPO) in the Normal Brain

This study uses immunohistochemistry to determine the regional distribution and cellular sources of TSPO in the normal mouse brain and emphasises the need for valid and methodologically robust verification of the selectivity of TspO ligands through the use of T SPO knockout tissues.

Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows

It is hypothesized that longitudinal imaging using TSPO positron emission tomography (PET) with 18F‐DPA‐714 could identify optimal treatment windows in a mouse model during the formation of HS, which is the most common type of drug‐resistant partial epilepsy.

Evaluation of the novel TSPO radiotracer [18F] VUIIS1008 in a preclinical model of cerebral ischemia in rats

Results suggest that [18F] VUIIS1008 could become a valuable tool for the diagnosis and treatment evaluation of neuroinflammation following ischemic stroke.

Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component

Behavioral tests and preclinical imaging techniques used for diagnose and describe the vascular pathological features associated to these diseases are focused on.

11C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis

This study investigated microglia activation in asymptomatic and symptomatic SOD1 mutated carriers, by using 11C‐PK11195 and PET imaging, and found the prototypical and most validated PET radiotracer, targeting the 18‐kDa translocator protein which is overexpressed in activated microglial activation.

References

SHOWING 1-10 OF 67 REFERENCES

Magnetic Resonance Microscopy and Immunohistochemistry of the CNS of the Mutant SOD Murine Model of ALS Reveals Widespread Neural Deficits

The extent to which several CNS structures are impacted in both murine models of ALS argues for a reevaluation of the nature of the pathogenesis of ALS since CNS structures involved in Parkinson’s and Alzheimer's diseases appear to be affected as well.

Comparative Magnetic Resonance Imaging and Histopathological Correlates in Two SOD1 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive and fatal disease due to motoneuron degeneration. Magnetic resonance imaging (MRI) is becoming a promising non-invasive approach to monitor the

Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis

It is suggested that the early activity of microglia/macrophages is involved in the early phase of motor neuron degeneration and studies involving immunomodulation in hmSOD1transgenic models need to consider effects on macrophages in peripheral nerves as well as tomicroglia in the spinal cord.

Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714

Using [18F]DPA-714, neuroinflammation in spinal cords of EAE-induced rats could be visualized by PET, offering a sensitive technique for monitoring neuroinflammatory lesions in the CNS and particularly in the spinal cord.

Vacuolization correlates with spin–spin relaxation time in motor brainstem nuclei and behavioural tests in the transgenic G93A‐SOD1 mouse model of ALS

MRI is a very sensitive tool to obtain correlates for neuronal degeneration in vivo and enables us to investigate a follow up at different time points of the disease, especially for therapeutic studies with respect to survival rates of motor neurons using mouse models.

Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28

Immune reactivity in a mouse model of familial ALS correlates with disease progression

The upregulation of proinflammatory factors during early presymptomatic stages as well as the expansion of immune activation as disease progresses in mutant SOD1 transgenic mice suggest that immune-inflammatory mechanisms could contribute to disease progression.

Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis

It is suggested that the cortical uptake of 18F-DPA-714 was increased in ALS patients during the “time of diagnosis” phase of the disease, which might improve the understanding of the pathophysiology of ALS and might be a surrogate marker of efficacy of treatment on microglial activation.
...